ZA200107502B - Lipoglycan compositions and methods of treating parasitic infections. - Google Patents

Lipoglycan compositions and methods of treating parasitic infections.

Info

Publication number
ZA200107502B
ZA200107502B ZA200107502A ZA200107502A ZA200107502B ZA 200107502 B ZA200107502 B ZA 200107502B ZA 200107502 A ZA200107502 A ZA 200107502A ZA 200107502 A ZA200107502 A ZA 200107502A ZA 200107502 B ZA200107502 B ZA 200107502B
Authority
ZA
South Africa
Prior art keywords
lipoglycan
compositions
methods
parasitic infections
composition
Prior art date
Application number
ZA200107502A
Other languages
English (en)
Inventor
Lloyd H Semprevivo
Original Assignee
Univ Massachusetts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Massachusetts filed Critical Univ Massachusetts
Publication of ZA200107502B publication Critical patent/ZA200107502B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0003Invertebrate antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/002Protozoa antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • A61P33/12Schistosomicides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA200107502A 1999-03-12 2001-09-11 Lipoglycan compositions and methods of treating parasitic infections. ZA200107502B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12393199P 1999-03-12 1999-03-12

Publications (1)

Publication Number Publication Date
ZA200107502B true ZA200107502B (en) 2003-02-26

Family

ID=22411778

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200107502A ZA200107502B (en) 1999-03-12 2001-09-11 Lipoglycan compositions and methods of treating parasitic infections.

Country Status (17)

Country Link
US (3) US6428793B1 (xx)
EP (1) EP1175226B1 (xx)
JP (1) JP2002538220A (xx)
AT (1) ATE439857T1 (xx)
AU (1) AU771373B2 (xx)
BR (1) BR0008949A (xx)
CA (1) CA2364507A1 (xx)
DE (1) DE60042776D1 (xx)
HU (1) HUP0200466A3 (xx)
MA (1) MA25347A1 (xx)
MX (1) MXPA01009206A (xx)
NO (1) NO20014411L (xx)
NZ (1) NZ514112A (xx)
PL (1) PL203789B1 (xx)
TR (3) TR200103231T2 (xx)
WO (1) WO2000053220A1 (xx)
ZA (1) ZA200107502B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756361B1 (en) * 1997-10-14 2004-06-29 Nabi Enterococcus antigens and vaccines
US7164520B2 (en) 2004-05-12 2007-01-16 Idc, Llc Packaging for an interferometric modulator
WO2006041613A2 (en) * 2004-10-05 2006-04-20 Nanomega Medical Corporation Nanoparticles for targeting hepatoma cells
WO2011047794A2 (en) 2009-10-21 2011-04-28 Eth Zurich Medical utility of glycan-binding proteins and glycans

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2598147B1 (fr) * 1986-04-30 1988-08-26 Pasteur Institut Immunogene isole de mollusques, son procede de preparation, reactifs de diagnostic des bilharzioses humaines, vaccins contre les schistosomiases et compositions immunisantes comprenant ledit immunogene.
FR2601021B2 (fr) * 1986-07-07 1988-11-18 Pasteur Institut Fraction immunogene active a l'egard des bilharzioses, sa preparation, compositions immunisantes la contenant
US5212298A (en) * 1989-08-16 1993-05-18 Monsanto Company Method for producing synthetic N-linked glycoconjugates
US5280113A (en) 1989-08-16 1994-01-18 Monsanto Company Method for producing synthetic N-linked glycoconjugates
US5679347A (en) * 1992-12-10 1997-10-21 Brigham And Women's Hospital Methods of isolating CD1-presented antigens, vaccines comprising CD1-presented antigens, and cell lines for use in said methods
US5541075A (en) * 1993-02-05 1996-07-30 Heska Corporation Carbohydrate-based vaccine and diagnostic reagent for trichinosis
BR9305075A (pt) * 1993-12-16 1995-08-08 Fundacao Oswaldo Cruz Antígeno para conferir imunidade protetora contra infecções helmínticas em humanos e animais,e processo de vacinação para aplicação na imunoprofilaxia de doenças helmintológicas de interesse veterinário e médico
AU5928999A (en) * 1998-09-21 2000-04-10 Richard D. Cummings Assays for helminth infections

Also Published As

Publication number Publication date
EP1175226A4 (en) 2005-01-05
US7204983B2 (en) 2007-04-17
US7063848B2 (en) 2006-06-20
WO2000053220A1 (en) 2000-09-14
NZ514112A (en) 2003-08-29
TR200103231T2 (tr) 2002-03-21
HUP0200466A3 (en) 2006-11-28
CA2364507A1 (en) 2000-09-14
NO20014411D0 (no) 2001-09-11
TR200202078T2 (tr) 2002-11-21
PL350989A1 (en) 2003-02-24
US20020160021A1 (en) 2002-10-31
AU771373B2 (en) 2004-03-18
US20060228382A1 (en) 2006-10-12
NO20014411L (no) 2001-11-09
HUP0200466A2 (en) 2002-06-29
US6428793B1 (en) 2002-08-06
DE60042776D1 (de) 2009-10-01
BR0008949A (pt) 2002-09-24
JP2002538220A (ja) 2002-11-12
AU3625100A (en) 2000-09-28
EP1175226B1 (en) 2009-08-19
MA25347A1 (fr) 2001-12-31
EP1175226A1 (en) 2002-01-30
ATE439857T1 (de) 2009-09-15
PL203789B1 (pl) 2009-11-30
TR200202066T2 (tr) 2004-12-21
MXPA01009206A (es) 2003-07-14

Similar Documents

Publication Publication Date Title
ES2137498T3 (es) Inmunogenos contra la hormona liberadora de gonadotropinas.
HU9601312D0 (en) Glucosamine disaccharides, method for their preparation, pharmaceutical composition comprising same, and their use
DK0636031T3 (xx)
AU4806197A (en) Method and potentiated composition for treating migraine
ZA96101B (en) Imidazol[4,5-c]quinoline amines
GR3032037T3 (en) Immunogen compounds having specifically an anti-cytokine effect, method of preparation, pharmaceutical compositions and kits containing them
UA40597C2 (uk) Вакцинна композиція,спосіб лікування ссавців, що страждають або сприйнятливі до інфекції, спосіб лікування ссавців, що страждають на рак, спосіб одержання вакцинної композиції, композиція ад'ювантів
MX9301706A (es) Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
AU7877900A (en) Method of obtaining cellular immune responses from proteins
ZA956412B (en) Mutant enterotoxin effective as a non-toxic oral adjuvant
GB9306731D0 (en) Vaccines
EP0979080A4 (en) METHOD FOR MODULATING THE IMMUNE REACTION IN AN INFECTIVE MAMMALIAN BY THE TRANSMUCOSAL ENTERING A MODULATING AGENT
AU2003212170A1 (en) Chemotherapeutic agents as anti-cancer vaccine adjuvants and therapeutic methods thereof
ZA200107502B (en) Lipoglycan compositions and methods of treating parasitic infections.
WO2000057908A3 (en) Attenuated dengue-1 virus vaccine
WO2001034184A3 (en) Methods and compositions for protection against bovine herpesvirus 1
CA2063721A1 (fr) Medicament immunostimulant a base de glycopeptidolipides polaires de mycobacterium chelonae
EP1131338A4 (en) PROCESS FOR PRODUCING HIGHLY PURIFIED INVASINATED PROTEIN AND USE OF SUCH PROTEIN
DE69931504D1 (de) Zusammensetzungen zur linderung der nebeneffekte des interleukin-2
AU2471201A (en) Plant lectins as mucosal adjuvants
WO2001002005A3 (en) Treatment of dentritic cells for induction of immune tolerance
EP1112746A3 (en) Eimeria strains as Coccidiosis vaccines
MY104932A (en) Immunomodulatory azaspiranes